Safety and potential efficacy of cyclooxygenase-2 inhibitors in coronavirus disease 2019

Safety and potential efficacy of cyclooxygenase-2 inhibitors in coronavirus disease 2019

10.1002/cti2.1159

Saved in:

Bibliographic Details
Main Authors:	Ong, S.W.X., Tan, W.Y.T., Chan, Y.-H., Fong, S.-W., Renia, L., Ng, L.F.P., Leo, Y.-S., Lye, D.C., Young, B.E.
Other Authors:	BIOLOGICAL SCIENCES
Format:	Article
Published:	John Wiley and Sons Inc 2021
Subjects:	COVID-19 COX-2 inhibitors interleukin-6 SARS-CoV-2
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/198700
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Similar Items

Mechanistic insights of host cell fusion of SARS-CoV-1 and SARS-CoV-2 from atomic resolution structure and membrane dynamics
by: Chakraborty, Hirak, et al.
Published: (2021)

Associations of viral ribonucleic acid (RNA) shedding patterns with clinical illness and immune responses in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection
by: Lee, P.H., et al.
Published: (2021)

Autoimmune sequelae after Delta or Omicron variant SARS-CoV-2 infection in a highly vaccinated cohort
by: Wee, Liang En, et al.
Published: (2024)

Extrapulmonary manifestations and complications of severe acute respiratory syndrome coronavirus 2 infection: a systematic review.
by: Cho, Jiacai, et al.
Published: (2021)

The polybasic insert, the RBD of the SARS-CoV-2 spike protein, and the feline coronavirus – evolved or yet to evolve
by: Budhraja, Anshul, et al.
Published: (2022)

Linear B-cell epitopes in the spike and nucleocapsid proteins as markers of SARS-CoV-2 exposure and disease severity
by: Amrun, S.N., et al.
Published: (2021)

Modelling lockdown and exit strategies for COVID-19 in Singapore
by: DICKENS, BORAME SUE LEE, et al.
Published: (2021)

Co-incidence of BA.1 and BA.2 at the start of Singapore's Omicron wave revealed by community and university campus wastewater surveillance
by: Chua, Desmond Feng Jun, et al.
Published: (2023)

Linear B-cell epitopes in the spike and nucleocapsid proteins as markers of SARS-CoV-2 exposure and disease severity
by: Siti Naqiah Amrun, et al.
Published: (2020)

Facing a disruptive threat: how can a nuclear medicine service be prepared for the coronavirus outbreak 2020?
by: Lam, Winnie Wing-Chuen, et al.
Published: (2023)

Coronavirus disease 2019 (COVID-19): an evidence map of medical literature
by: LIU NAN, et al.
Published: (2020)

Evaluation of the safety and immunogenicity of different COVID-19 vaccine combinations in healthy individuals: study protocol for a randomized, subject-blinded, controlled phase 3 trial [PRIBIVAC]
by: Poh, Xuan Ying, et al.
Published: (2023)

The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak- A n update on the status
by: Guo, Y.-R., et al.
Published: (2021)

Single-Cell RNA-seq Reveals Angiotensin-Converting Enzyme 2 and Transmembrane Serine Protease 2 Expression in TROP2+ Liver Progenitor Cells: Implications in Coronavirus Disease 2019-Associated Liver Dysfunction
by: Seow, Justine Jia Wen, et al.
Published: (2022)

Longitudinal wastewater-based surveillance for SARS-CoV-2 in high-density student dormitories in Singapore
by: Ng, Wei Jie, et al.
Published: (2024)

Waning of specific antibodies against Delta and Omicron variants five months after a third dose of BNT162b2 SARS-CoV-2 vaccine in elderly individuals
by: Goh, Yun Shan, et al.
Published: (2023)

Third dose of BNT162b2 improves immune response in liver transplant recipients to ancestral strain but not Omicron BA.1 and XBB
by: Chang, Zi Wei, et al.
Published: (2023)

A novel virtual screening procedure identifies Pralatrexate as inhibitor of SARS-CoV-2 RdRp and it reduces viral replication in vitro
by: Zhang, Haiping, et al.
Published: (2021)

Memory T Cell Responses Targeting the SARS Coronavirus Persist up to 11 Years Post-Infection
by: Ng, Oi Wing, et al.
Published: (2016)

Early pathogenesis profiles across SARS-CoV-2 variants in K18-hACE2 mice revealed differential triggers of lung damages
by: Aw, Zhen Qin, et al.
Published: (2023)

Results from a systematic programme of evaluating COVID-19 reinfection cases in the early phase of the pandemic, Singapore
by: Tan, Glorijoy Shi En, et al.
Published: (2023)

Asymptomatic COVID-19: disease tolerance with efficient anti-viral immunity against SARS-CoV-2
by: Chan, Yi-Hao, et al.
Published: (2022)

COVID-19 vaccination before or during pregnancy results in high, sustained maternal neutralizing activity to SARS-CoV-2 wild-type and Delta/Omicron variants of concern, particularly following a booster dose or infection
by: Mahyuddin, Aniza P., et al.
Published: (2024)

An allosteric mechanism for potent inhibition of SARS-CoV-2 main proteinase
by: Zhang, Yunju, et al.
Published: (2024)

Factors affecting duration of SARS-Cov-2 viral shedding in mildly symptomatic patients isolated in a community facility
by: Cheng, Hui Mei, et al.
Published: (2021)

Screening, expression, and identification of nanobody against SARS-CoV-2 spike protein
by: Su, Qianling, et al.
Published: (2023)

EVALUATION OF ADAPTIVE IMMUNITY INDUCED BY VACCINATION AND INFECTION
by: NICHOLAS KHOO KIM HUAT
Published: (2023)

Disease prevalence matters: Challenge for SARS-CoV-2 testing
by: Lau, Chin-Shern, et al.
Published: (2022)

Laboratory practice in the face of Covid-19
by: Lau, C.S., et al.
Published: (2021)

Development and characterization of a SARS-coronavirus replicon cell line
by: GE FENG
Published: (2010)

Coronavirus disease 2019 (COVID-19) pandemic and pregnancy
by: Dashraath, Pradip, et al.
Published: (2023)

Performance of an automated chemiluminescent immunoassay for SARS-COV-2 IgM and head-to-head comparison of Abbott and Roche COVID-19 antibody assays
by: CS, L., et al.
Published: (2022)

Vaccines and allergic reactions: The past, the current COVID-19 pandemic, and future perspectives
by: Sampath, V, et al.
Published: (2022)

Positive anti-SSA/Ro antibody in a woman with SARS-CoV-2 infection using immunophenotyping: A case report
by: Huang, P.-I., et al.
Published: (2021)

Immune and pathophysiologic profiling of antenatal coronavirus disease 2019 in the GIFT cohort: A Singaporean case-control study
by: Gu, Yue, et al.
Published: (2023)

Serological Approaches for COVID-19: Epidemiologic Perspective on Surveillance and Control
by: Lee, C.Y.-P., et al.
Published: (2021)

Performance of two rapid point of care SARS-COV-2 antibody assays against laboratory-based automated chemiluminescent immunoassays for SARS-COV-2 IG-G, IG-M and total antibodies
by: Lau, C. S., et al.
Published: (2022)

SARS-CoV-2 titers in wastewater are higher than expected from clinically confirmed cases
by: Wu, F., et al.
Published: (2021)

Making waves : wastewater surveillance of SARS-CoV-2 for population-based health management
by: Thompson, Janelle R., et al.
Published: (2021)

Making waves: wastewater surveillance of SARS-CoV-2 in an endemic future
by: Wu, Fuqing, et al.
Published: (2022)